Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
PMG Research of Wilmington
mi
from
Wilmington, NC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Community Research
mi
from
Cincinnati, OH
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Community Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Lab of Northeastern Pennsylvania
mi
from
Clarks Summit, PA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Lab of Northeastern Pennsylvania
mi
from
Clarks Summit, PA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
SleepMed of SC
mi
from
Columbia, SC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
SleepMed of SC
mi
from
Columbia, SC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
University of Tennesee Health Science Center
mi
from
Memphis, TN
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
University of Tennesee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Future Research Trials of Neurology
mi
from
Austin, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Future Research Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Clinical Trial Network
mi
from
Houston, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Paragon Research Center
mi
from
San Antonio, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Paragon Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Medicine Associates
mi
from
Seattle, WA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Medicine Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Targeted Management Intervention for African-American Men With TIA or Stroke
Targeted Management Intervention for African-American Men With TIA or Stroke.
Status: Enrolling
Updated:  1/31/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Targeted Management Intervention for African-American Men With TIA or Stroke
Targeted Management Intervention for African-American Men With TIA or Stroke.
Status: Enrolling
Updated: 1/31/2017
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Status: Enrolling
Updated:  1/31/2017
MS Center at Evergreen Health
mi
from
Kirkland, WA
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
Status: Enrolling
Updated: 1/31/2017
MS Center at Evergreen Health
mi
from
Kirkland, WA
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
University of Colorado
mi
from
Aurora, CO
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Meridien Research
mi
from
Tampa, FL
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Fort Wayne Neurological Center
mi
from
Fort Wayne, IN
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Fort Wayne Neurological Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
MidAmerica Neuroscience Institute
mi
from
Lenexa, KA
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
MidAmerica Neuroscience Institute
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
QUEST Research Institute
mi
from
Bingham Farms, MI
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
QUEST Research Institute
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Great Falls Cllinic
mi
from
Great Falls, MT
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Great Falls Cllinic
mi
from
Great Falls, MT
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Empire Neurology, PC
mi
from
Latham, NY
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Empire Neurology, PC
mi
from
Latham, NY
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Winthrop University Hospital
mi
from
Mineola, NY
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated:  1/31/2017
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status: Enrolling
Updated: 1/31/2017
Central Texas Neurology Consultants, P.A.
mi
from
Round Rock, TX
Click here to add this to my saved trials
Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  1/31/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 1/31/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Status: Enrolling
Updated:  1/31/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Sex and Age Ultrasound Response to Differential Jugular Vein Pressure
Status: Enrolling
Updated: 1/31/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trichuris Suis Ova in Peanut and Tree Nut Allergy
Trichuris Suis Ova Therapy for Mild to Moderate Peanut and Tree Nut Allergy in Adults and Children
Status: Enrolling
Updated:  2/2/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Trichuris Suis Ova in Peanut and Tree Nut Allergy
Trichuris Suis Ova Therapy for Mild to Moderate Peanut and Tree Nut Allergy in Adults and Children
Status: Enrolling
Updated: 2/2/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Executive Function/Metacognitive Training for At-Risk Preschoolers
Executive Function/Metacognitive Training for At-Risk Preschoolers
Status: Enrolling
Updated:  2/2/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Executive Function/Metacognitive Training for At-Risk Preschoolers
Executive Function/Metacognitive Training for At-Risk Preschoolers
Status: Enrolling
Updated: 2/2/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Sacramento, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
San Diego, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
San Francisco, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Santa Ana, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Stanford, CA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Centennial, CO
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Centennial, CO
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
New Haven, CT
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Delray Beach, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Oakland Park, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Oakland Park, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Orlando, FL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Decatur, GA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Chicago, IL
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Baltimore, MD
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Rockville, MD
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Lexington, MA
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Lexington, MA
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Minneapolis, MN
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Bronx, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
New York, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Orangeburg, NY
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Orangeburg, NY
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Durham, NC
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Cincinnati, OH
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)
A Multi-Center, Randomized, Double-Blind, 12-Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials